Bill > HF3452

This bill classifies kratom, specifically the compounds mitragynine and 7-hydroxymitragynine, as a Schedule II controlled substance under Minnesota law, meaning it will be regulated similarly to other drugs with a high potential for abuse but also accepted medical uses. This reclassification is achieved by amending Minnesota Statutes 2024, section 152.02, subdivision 3, which lists substances in Schedule II, by adding kratom's active compounds to this list, and by repealing Minnesota Statutes 2024, section 152.027, subdivision 7, which previously addressed separate criminal penalties for the sale or possession of kratom, particularly concerning individuals under 18. The term "controlled substance" refers to drugs or chemicals whose manufacture, possession, or use is regulated by the government. Schedule II substances are those that have a high potential for abuse, which may lead to severe psychological or physical dependence, but also have currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.

Justice

https://www.revisor.mn.gov/bills/94/2026/0/HF/3452/